PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginiagrid.412587.dgrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.\', \'Division of Infectious Diseases & International Health, Department of Medicine, University of Virginiagrid.412587.dgrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.\', \'Division of Laboratory Medicine, Department of Pathology, University of Virginiagrid.412587.dgrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.\', \'Division of Cardiology, Department of Medicine, University of Virginiagrid.412587.dgrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.\', \'College of Arts and Sciences, Cornell University, Ithaca, New York, USA.\', \'The Wistar Institute, Philadelphia, Pennsylvania, USA.\', \'Division of Hematology and Oncology, Department of Medicine, University of Virginiagrid.412587.dgrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/spectrum.02560-21
?:doi
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 35196802
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
is ?:relation_isRelatedTo_publication of
?:title
  • Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35196802>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35196802>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all